Akili

Acquired

Akili is a biotech company in Boston, United States, founded in 2011. It has raised $178.0M across 7 rounds, most recently a $110.0M Series D in April 2021.

Akili Interactive

Employees
51–200
Founded
2011
Business Model
B2C
Total Funding
$178.0M
Last Round
$110.0M Series DApr 2021
Rounds
7
Type
Public
Acquisition Date
May 2024

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 11 investors for this company. The full record is or through the API.

About

Akili Interactive is a digital therapeutics company creating a new class of cognitive medicines delivered through engaging video game experiences. Its flagship products, EndeavorRx (FDA-authorized for children with ADHD) and EndeavorOTC (clinically proven for adults with ADHD), combine neuroscience with proprietary game-based technology to improve attention and focus.

Summary

It lists 51–200 employees. It has raised $178.0M in total across 7 rounds, most recently a $110.0M Series D round in Apr 2021. Investors include Polaris Partners, Temasek and Social Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionMay 2024

Sign up to see all 10 events

Funding: Angel through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Akili on Indexed.vc
<a href="https://indexed.vc/companies/akili"><img src="https://indexed.vc/api/badge/company/akili" alt="Akili on Indexed.vc" width="260" height="76" /></a>